In Depth 27 Jan 2021 Single-Cell Sequencing: Paving the Way for Precision Medicine Next-generation sequencing techniques to determine an individual’s unique genetic code gave rise to personalized treatments. Single-cell sequencing is the next step towards making precision medicine more accurate. Each cell in our body is unique. Even genetically identical cells can behave differently in response to a certain treatment. With next-generation sequencing, scientists can study how the […] January 27, 2021 - 7 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
News and Trends 14 Oct 2020 Spatial Transcriptomics Landscape Shifts With Two Major Acquisitions The Swedish firm Cartana and US-based ReadCoor have recently been snapped up by the US giant 10x Genomics to get hold of their spatial transcriptomics technology. What impact will these acquisitions have on the burgeoning field going forward? Last week, 10x Genomics took over ReadCoor for a smooth €298M ($350M). This followed the acquisition of […] October 14, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 1 Jun 2020 How Personal Genomics Companies Are Changing Drug Development In recent years, companies offering direct-to-consumer genomics tests have started switching the business model and venturing into drug development. Amidst criticism on data protection and lack of transparency, personal genomics companies are leveraging their unique position to generate genomics data to strike lucrative deals with pharma companies. Thanks to cheaper data acquisition and convenient analysis, […] June 1, 2020 - 6 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
News and Trends 19 Nov 2019 US-French Deal to Tailor Ultrasound Therapy to Brain Cancer Patients The French company CarThera has teamed up with the US firm Kiyatec to study the effects on individual patients of an ultrasound therapy to deliver brain cancer drugs to the brain. Under the agreement, Kiyatec will test the effects of chemotherapy on cells taken from CarThera’s ongoing phase I/II trial in patients with brain cancer. […] November 19, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 23 Oct 2019 Channeling the Power of AI into Personalizing Medicine Artificial intelligence has been much discussed of late, but will it really help us solve important problems like how to bring personalized medicine to as many patients as possible? Kate Hilyard, COO of Healx in Cambridge in the UK, believes it can. Getting a drug to clinical trials currently requires a large investment of both […] October 23, 2019 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 15 Oct 2019 Four New Technologies That Will Change Cancer Treatment New approaches to tame the immune system in the fight against cancer are getting us closer to a future where cancer becomes a curable disease. Personalized vaccines, cell therapy, gene editing and microbiome treatments are four technologies that will change the way cancer is treated. Curing cancer is certainly one of the big challenges of […] October 15, 2019 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Sep 2019 IBM’s Watson for Genomics Launches in First European Hospital The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of […] September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2019 ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment Two companies based in Lausanne, Switzerland — ADC Therapeutics and the genomics company SOPHiA Genetics — have signed a deal to identify patients most likely to respond to a blood cancer drug. ADC Therapeutics will send SOPHiA Genetics blood samples collected from an ongoing phase II trial. The trial is testing a treatment for patients […] August 6, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 23 Apr 2019 Combining DNA and RNA Testing Could Improve Precision Medicine for Cancer An international clinical trial has shown that extending cancer testing beyond genetic mutations has potential to improve the personalized treatment of cancer. In recent years, the field of precision medicine has been rapidly growing and is bringing a lot of hope to both patients and physicians, especially in the diagnosis and treatment of […] April 23, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2018 Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials A European trial has proved the feasibility and efficacy of treating cancer with a personalized immunotherapy tailored to each patient. The phase I/II trial, run across six European centers, tested a combination of two personalized vaccines in patients with glioblastoma, an aggressive form of brain cancer. The first vaccine was designed to immunize the patients […] December 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2018 British Company Raises €37M to Personalize Therapies with Machine Learning Genomics, a company based in Oxford, has increased the amount raised in a Series B round that will fund further development of its genomics technology for personalized medicine. The company adds a further €9M (£8M) to the round with the participation of Foresite Capital and F-Prime Capital, two renowned US life sciences investors. The previous […] December 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2018 UK Project Hits 100,000 Genomes Target In a step forward for the world of personalized medicine, the UK Government-backed 100,000 Genomes Project has reached its sequencing target. The project, which is one of the largest of its kind, was designed to collect genomic data to improve the capacity of personalized medicine, as well as learning more about the genetic basis of […] December 6, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email